IL2 and neoplasm: As stem cells are known to have tropism for tumor cells in the brain [13], [33], [37]–[40], stem cell-mediated therapy is emerging as a strategy to effectively deliver molecular therapies, like IFN-beta [41], IL-2 [40], [42], cytosine deaminase [43], and oncolytic adenovirus [44], in the brain.